H.C. Wainwright Flag KRRO-121 as Independent Value Driver for Korro Bio, Inc. (KRRO)

TheFly reported connected January 29 that H.C. Wainwright upgraded KRRO from Neutral to Buy with a $20 terms target. The steadfast highlighted KRRO-121 arsenic a second, independently risk-mitigated plus and described it arsenic a “call option” that is abstracted from the company’s earlier KRRO-110 program. H.C. Wainwright highlighted the autarkic imaginable of KRRO-121 by pointing retired that KRRO’s shares are trading adjacent to zero endeavor value.

Similarly, connected the aforesaid day, Chardan Capital besides upgraded Korro Bio, Inc. (NASDAQ:KRRO) from Neutral to Buy with a $15 terms people pursuing the company’s expert day. The upgrade reflected the firm’s presumption that KRRO has “turned the page,” supported by beardown preclinical information for KRRO-121.

Korro Bio, Inc. (NASDAQ:KRRO) is simply a biopharmaceutical institution processing precision familial medicines by editing RNA to dainty uncommon and prevalent diseases. Using its proprietary OPERA platform, KRRO advances RNA‑editing therapies, including objective and preclinical programs.

While we admit the imaginable of KRRO arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 12 Best Multibagger Stocks to Buy Heading into 2026 and 7 Best Rising Tech Stocks to Buy Now.

Disclosure: None.